| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $94.5M | — | -23.9% |
| Cost of Revenue | $15.9M | — | -50.7% |
| R&D Expense | $13.1M | — | -7.4% |
| SG&A Expense | $16.0M | — | -30.3% |
| Operating Income | -$8.3M | — | +54.4% |
| Interest Expense | $13.7M | — | -4.5% |
| Pre-tax Income | -$17.7M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $115.6M | +14.6% | -9.6% |
| Accounts Receivable | $77.3M | -55.8% | -19.5% |
| Current Assets | $287.0M | -13.8% | +3.3% |
| Total Assets | $853.0M | -11.4% | -16.6% |
| Current Liabilities | $313.9M | -15.8% | -3.4% |
| Long-term Debt |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $28.9M | — | -7.5% |
| Capital Expenditures | $425K | — | -17.5% |
| Investing Cash Flow | -$3.5M | — | +31.8% |
| Financing Cash Flow | -$3.3M | — | -69.8% |
| Free Cash Flow | $28.5M | — | -7.4% |
| +54.5% |
| Income Tax | $1.0M | — | +235.2% |
| Net Income | -$43.1M | — | -13.3% |
| EPS (Basic) | -$4.89 | — | -7.0% |
| $568.2M |
| -0.5% |
| -0.7% |
| Stockholders' Equity | -$72.8M | -140.9% | -216.2% |